Curtana Pharmaceuticals Company
Curtana is a biopharmaceutical company that has developed therapies for the treatment of the most aggressive types of brain cancer.
Last Funding Date:
2017
Technology:
Small Molecules
Last Funding Type:
Grant
Investors Number:
3
Industry:
Biopharma, Biotechnology, Pharmaceutical
Founded Date:
2013
Investor Type:
Seed
Employee Number:
1-10
Total Funding:
52288
Headquarters:
Austin, Texas, United States
Estimated Revenue:
Less than $1M
Funding Status:
Seed